Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway

Immunology

Volumn 96, Issue 3, 1999, Pages 498-504

  Taylor Robinson, A W ^a   Smith, E C ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; HOST RESISTANCE; IMMUNOMODULATION; MALARIA; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM CHABAUDI; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, CD28; ANTIGENS, CD80; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALARIA; MICE; MICE, INBRED STRAINS; PARASITEMIA; PLASMODIUM CHABAUDI; TH1 CELLS; TH2 CELLS;

EID: 0033027828     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00718.x     Document Type: Article

References (35)

1. THOMPSON C.B. (1995) Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 81, 979.
2. KUCHROO V.K., DAS M.P., BROWN J.A. et al. (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80, 707.
3. FREEMAN G.J., BOUSSIOTIS V.A., ANUMANTHAN A. et al. (1995) B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2, 523.
4. MATULONIS U., DOSIOU C., FREEMAN G. et al. (1996) B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct. J Immunol 156, 1126.
5. LINSLEY P.S., BRADY W., GROSMAIRE L., ARUFFO A., DAMLE N.K. & LEDBETTER J.A. (1991) Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 173, 721.
6. AZUMA M., ITO D., YAGITA H. et al. (1993) B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366, 76.
7. HATHCOCK K.S., LASZIO G., PUCILLO C., LINSLEY P. & HODES R.J. (1994) Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function. J Exp Med 180, 631.
8. LINSLEY P.S., BRADY W., URNES M., GROSMAIRE L.S., DAMLE N.K. & LEDBETTER J.A. (1991) CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 174, 561.
9. WATERHOUSE P., PENNINGER J.M., TIMMS E. et al. (1995) Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985.
10. LENSCHOW D.J., WALUNAS T.L. & BLUESTONE JA. (1996) CD28/B7 system of T cell costimulation. Annu Rev Immunol 14, 233.
11. TAYLOR-ROBINSON A.W. (1995) Regulation of immunity to malaria: Valuable lessons learned from murine models. Parasitol Today 11, 334.
12. + T-cell clones reactive to the murine malaria parasite Plasmodium chabaudi. Immunology 77, 99.
13. + T-cell lines raised against Plasmodium chabaudi show characteristics of either Th1 or Th2 cells. Parasite Immunol 15, 301.
14. + T cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection. Eur J Immunol 24, 158.
15. TAYLOR-ROBINSON A.W., PHILLIPS R.S., SEVERN A., MONCADA S. & LIEW F.Y. (1993) The role of Th1 and Th2 cells in a rodent malaria infection. Science 260, 1931.
16. + T cell subsets to Plasmodium chabaudi chabaudi in B cell-deficient mice. Int Immunol 5, 1343.
17. TAYLOR-ROBINSON A.W. & PHILLIPS R.S. (1994) B cells are required for the switch from Th1- to Th2-regulated immune responses to Plasmodium chabaudi chabaudi infection. Infect Immun 62, 2490.
18. TAYLOR-ROBINSON A.W. & PHILLIPS R.S. (1996) Reconstitution of B cell-depleted mice with B cells restores Th2-type immune responses during Plasmodium chabaudi chabaudi infection. Infect Immun 64, 366.
19. VON DER WEID T., HONARVAR N. & LANGHORNE J. (1996) Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection. J Immunol 156, 2510.
20. ROMAGNANI S. (1997) Role of Th1/Th2 cells in protection against infectious agents. In: The Th1/Th2 Paradigm in Disease, p. 63. R. G. Landes Company, Austin.
21. LENSCHOW D.J., HO S.C., SATTAR H. et al. (1995) Differential effects of anti-B7-1 and B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 181, 1145.
22. HAN S., HATHCOCK K., ZHENG B., KEPLER T.B., HODES R. & KELSOE G. (1995) Cellular interaction in germinal centers: Roles of CD40 ligand and B7-2 in established germinal centers. J Immunol 155, 556.
23. LEDBETTER J.A. & HERZENBERG L.A. (1979) Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 47, 63.
24. SNAPPER C.M. & PAUL W.E. (1987) Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236, 944.
25. SHARPE A.H. (1995) Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice. Curr Opin Immunol 7, 389.
26. OCKENHOUSE C.F., TEGOSHI T., MAENO Y. et al. (1992) Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med 176, 1183.
27. JAKOBSEN P.H., MORRIS-JONES S., RONN A. et al. (1994) Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. Immunology 83, 665.
28. ROGERSON S.J., CHAIYAROJ S.C., NG K., REEDER J.C. & BROWN G.V. (1995) Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J Exp Med 182, 15.
29. CORKY D.B., REINER S.L., LINSLEY P.S. & LOCKSLEY R.M. (1994) Differential effects of blockage of CD28 B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J Immunol 153, 4142.
30. PERRIN P.J., MALDONADO J.H., DAVIS T.A., JUNE C.H. & RACKE M.K. (1996) CTLA-4 blockage enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J Immunol 157, 1333.
31. BORRIELLO F., SETHNA M.P., BOYD S.D. et al. (1997) B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6, 303.
32. YELLIN M.J., SIPPEL K., INGHIRAMI G. et al. (1994) CD40 molecules induce down-modulation and endocytosis of T cell surface T cell B cell activating molecule/CD40-L. Potential role in regulating helper effector function. J Immunol 152, 598.
33. VAN KOOTEN C., GAILLARD C., GALIZZI J.P. et al. (1994) B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur J Immunol 24, 787.
34. VAN ESSEN D., KIKUTANI H. & GRAY D. (1995) CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378, 620.
35. FINCK B.K., LINSLEY P.S. & WOFSY D. (1994) Treatment of murine lupus with CTLA4Ig. Science 265, 1225.